Apogee Therapeutics, Inc.
APGE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$65 | -$66 | -$55 | -$67 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12 | $11 | $11 | $8 |
| Change in WC | -$1 | -$7 | -$3 | -$6 |
| Other Non-Cash | -$1 | -$1 | -$2 | -$2 |
| Operating Cash Flow | -$54 | -$62 | -$48 | -$68 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | -$4 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$108 | -$47 | -$98 | -$61 |
| Inv. Sales/Matur. | $126 | $126 | $116 | $107 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $18 | $78 | $13 | $46 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $20 | $1 | $1 | $44 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $20 | $1 | $1 | $44 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$17 | $17 | -$35 | $23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $124 | $107 | $142 | $119 |
| End Cash | $108 | $124 | $107 | $142 |
| Free Cash Flow | -$54 | -$63 | -$53 | -$68 |